Keyphrases
Multiple Sclerosis
100%
Wearable Devices
35%
National Cohort Study
33%
Disability Pension
31%
Expanded Disability Status Scale
27%
COVID-19
26%
Disability
22%
Lockdown
19%
Confidence Interval
18%
Multiple Sclerosis Treatment
17%
Heart Rate
16%
Clinically Stable
15%
Remote Monitoring
15%
Relapsing-remitting multiple Sclerosis
15%
Walk Test
14%
Clinical Outcomes
14%
Remote Assessment
13%
Disability Definition
13%
Smartphone Device
13%
Natalizumab Treatment
13%
Convolutional Autoencoder
13%
Risk Factors
13%
Time to First Treatment
13%
Adverse Events
13%
Socioeconomic Risk
13%
Late-onset multiple Sclerosis
13%
Disability Progression
13%
Age Factors
13%
Aging
13%
Spain
13%
Late-onset
13%
Stable Disease
13%
Major Depressive Disorder
13%
Incident Atrial Fibrillation
13%
Autonomic Response
13%
Comparative Effectiveness
13%
Biopsychosocial Approach
13%
Behavior Change
13%
Low Risk
13%
Wristband
13%
Italy
13%
Retinal Vein Occlusion
13%
Income Loss
13%
Automatic Assessment
13%
Retinal Artery Occlusion
13%
COVID-19 Lockdown
13%
Walking Distance
13%
Dimethyl Fumarate
13%
Teriflunomide
13%
Retinal Vascular Occlusion
11%
Medicine and Dentistry
Multiple Sclerosis
90%
Wearable Sensor
30%
Cohort Analysis
28%
Disease
27%
Disability Pension
26%
Expanded Disability Status Scale
18%
Walk Test
16%
Remote Sensing
15%
Symptom
14%
COVID-19
13%
Atrial Fibrillation
13%
Retina Artery Occlusion
13%
Retina Vein Occlusion
13%
Fumaric Acid Dimethyl Ester
13%
Teriflunomide
13%
Retina Blood Vessel Occlusion
10%
Disease Course
7%
Disease Modifying Therapy
7%
Electrocardiogram
7%
Accelerometer
6%
Hazard Ratio
5%
Autonomic Nervous System
5%
Six Minute Walk Test
5%
Infection
5%
